The following is very real, first-hand account of one explorer’s exploits around the world in pursuit of the finest cannabis flowers the Earth has to offer. Never before has such a journey been attempted…until now.
Acreage Pharms, an Invictus MD (GENE.V) subsidiary, entered into a five-year supply and distribution deal with Deutsche Medizinalcannabis for 10,000 kilograms of dried flower.
Canadian LPs rush to supply Germany’s constrained marijuana market (TGOD.T) (ASNT.T) (CXXI.C) (CROP.C)
Germany’s medical marijuana market is lucrative, and Canadian LPs want in. Thankfully, Germany also wants Canadian companies to show them what’s up.
C21 Investments (CXXI.C) to raise the equivalent of their market cap in US and global expansion fuel
One thing I love about US-focused cannabis roll-up C21 Investments (CXXI.C) is their ‘coming through’ attitude.
TGOD’s (TGOD.T) is providing substantive updates on its operations, detailing the company’s Mexican and European expansion, the latest round of financing and additions to its braintrust.
Naturally Splendid (NSP.V) to infuse Crop Infrastructure’s (CROP.C) CannaDrink with its proprietary HempOmega powder
CannaDrink, CROP Infrastructure’s (CROP.C) in-development functional beverage, will now include a hemp seed additive designed by Naturally Splendid (NSP.V).
The Toronto Stock Exchange has approved TGOD’s (TGOD.T) acquisition of HemPoland, a Polish CBD-oil manufacturer which is TGOD’s first European subsidiary.
CROP Infrastructure (CROP.C) has released a deluge of good news for investors in recent weeks, including harvest updates, newly secured properties and two developments in the company’s Italian endeavors.
The market has kinda shrugged at it, but The Green Organic Dutchman (TGOD.T) put out news yesterday they’re acquiring a significant European organic CBD oil brand, with associated licensed flower and seed production, consumer product lines, and multi-country distribution.
New cannabis player Vinergy Resources (VIN.C) has announced a surprise deal to acquire a potential 51% stake in an established a European growhouse, nursery, and tissue culture player with decades of history in the business.